Assyro AI

Orange Book product · Brand (NDA)

ZECUITY

SUMATRIPTAN SUCCINATE

Brand (NDA)NDA 202278DISCN TEVA BRANDED PHARM

At a glance

Jan 17, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

9

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 17, 2013

    13 yr 7 mo ago

  2. Today

  3. Patent 7973058 expires

    Listed method-of-use patent (U-1328) expiration.

    Apr 12, 2027

    in 10 mo

  4. Patent 8155737 expires

    Listed method-of-use patent (U-1328) expiration.

    Apr 12, 2027

    in 10 mo

  5. Patent 8470853 expires

    Listed method-of-use patent (U-1328) expiration.

    Apr 12, 2027

    in 10 mo

  6. Patent 8597272 expires

    Listed drug product patent expiration.

    Apr 12, 2027

    in 10 mo

  7. Patent 9427578 expires

    Listed drug product patent expiration.

    Apr 12, 2027

    in 10 mo

  8. Patent 9272137 expires

    Listed drug product patent expiration.

    Sep 07, 2027

    in 1 yr 3 mo

  9. Patent 8366600 expires

    Listed method-of-use patent (U-1327) expiration.

    Apr 21, 2029

    in 2 yr 11 mo

  10. Patent 8983594 expires

    Listed drug product patent expiration.

    Nov 19, 2030

    in 4 yr 6 mo

  11. Patent 9327114 expires

    Listed drug product patent expiration.

    Oct 08, 2032

    in 6 yr 5 mo

Pharmaceutical detail

Active ingredient

SUMATRIPTAN SUCCINATE

Strength

EQ 6.5MG BASE/4HR

Dosage form

SYSTEM

Route

IONTOPHORESIS

TE code

Not listed

Application

NDA 202278

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (9)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7973058Apr 12, 2027in 10 mo
U-1328
8155737Apr 12, 2027in 10 mo
U-1328
8470853Apr 12, 2027in 10 mo
U-1328
8597272Apr 12, 2027in 10 mo
Product
9427578Apr 12, 2027in 10 mo
ProductU-1328
9272137Sep 07, 2027in 1 yr 3 mo
Product
8366600Apr 21, 2029in 2 yr 11 mo
U-1327
8983594Nov 19, 2030in 4 yr 6 mo
ProductU-1328
9327114Oct 08, 2032in 6 yr 5 mo
ProductU-1328
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.